by Mike Lavine | May 16, 2025 | District Court, PTAB News, Trial Institution
By Mike Lavine – On April 16, 2025, the Patent Trial and Appeal Board (PTAB) denied institution of inter partes review (IPR) for several claims of U.S. Patent No. 7,187,307, owned by Universal Connectivity Technologies, Inc. HP Inc., Dell Technologies Inc., Dell...
by Carl Kukkonen | May 8, 2025 | PTAB News, PTAB Trial Basics, Trial Institution
By Carl Kukkonen – In two recent decisions, the Patent Trial and Appeal Board (PTAB) denied institution of inter partes review (IPR) proceedings sought by Apple Inc. against Haptic, Inc. regarding U.S. Patent No. 9,996,738 B2. These decisions—IPR2024-01475 and...
by David Maiorana | May 7, 2025 | PTAB News, PTAB Trial Basics, Trial Institution
By David Linden, Dave Maiorana, and Sue Gerber – On August 22, 2024, Hulu, LLC (“Hulu”) filed two separate petitions for inter partes review (“IPR”) of U.S. Patent No. 11,463,768 (“the ’768 Patent”), assigned to Piranha Media Distribution, LLC (“Piranha”). The...
by Matthew Johnson | May 1, 2025 | 325(d) issues, Trial Institution
By Levent Herguner and Matt Johnson – In Thermaltake Technology Co., Ltd. et al v. Chien-Hao Chen et al, IPR2024-01230, Paper 12 (PTAB Feb. 19, 2025), the PTAB granted the institution of inter partes review (“IPR”) while an ex parte reexamination (“EPR”) on the...
by Matthew Johnson | Apr 22, 2025 | Time Limits, Trial Institution
By Dalton Earich and Matt Johnson – In 2985 LLC d/b/a Mountain Voyage Company, LLC v. The Ridge Wallet LLC, a Patent Trial and Appeal Board (“PTAB”) panel denied inter partes review (“IPR”) institution where the petition was time barred under 35 U.S.C. § 315(b)...
by Sue Gerber | Apr 18, 2025 | Expert Witnesses, Trial Institution
By Sue Gerber – It is relatively uncommon for parties to submit expert declarations in the preliminary-response phase of an IPR proceeding, but recently the Patent Owner in Imperative Care, Inc. v. Inari Medical, Inc. effectively used that strategy to defeat...
